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Abstract 
  Mature cystic teratomas are common benign tumors of the ovary. 
They are bilateral in about 10 % of cases. Carcinoma arising from mature 
cystic teratomas are quite rare and amounts to 0.17 – 2 %. Malignant 
transformation is most commonly seen in  post-menopausal age group, and 
these carcinomas are treated with surgical excision and adjuvant 
chemotherapy.  In this study, we present a case of a 70 year old lady with 
carcinoma arising from mature cystic teratoma. She was evaluated clinically, 
biochemically and with imaging studies, and  was taken up for staging 
laparotomy, Total abdominal hysterectomy with bilateral salpingo 
opherectomy. Post operatively chemotherapy was given to her. Hence, this 
rare type of malignant transformation should be kept in mind when faced 
with a dermoid cyst, especially in older patients, or in patients with larger 
than usual cysts. 
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1.  Introduction  
  Germ cell tumors account approximately for 30 % of all ovarian 
tumors. 95 % of all germ cell tumors are mature cystic teratomas, (MCT). 
MCT is composed of well differentiated cell layers (ectoderm, mesoderm, 
endoderm), and it accounts for 10 - 20 % of all ovarian tumors in females of 
reproductive age group. Malignant transformation in a MCT of the ovary is 
rare, accounting for about 0.17 – 2 %. Most common malignancy is 
squamous cell carcinoma (SCC) (75%), while other malignancies are 
adenocarcinoma and differentiated carcinoma, sarcoma and papillary 
carcinoma.  
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2. Case Report 
  A 70 year old lady, P5 L5, who is post-menopausal for 20 years, 
came with complaints of abdominal distention for 3 months. It was 
associated with abdominal pain, loss of weight and appetite for 1 month. She 
also complained of vomiting 2 – 3 episodes/day, but there were no 
complaints of white discharge per vaginum or post-menopausal bleeding. On 
examination, she was poorly nourished. No inguinal or supraclavicular nodes 
felt. Vitals were stable. On palpation, a mass was felt in the lower abdomen 
extending up to umbilicus. It was firm, non tender and the lower border was 
not made out. The mass moved with respiration. Per speculum – vulva and 
vagina were pale, rugosity absent and her cervix appeared healthy. Per 
vaginum – uterine size could not be made out. A firm 22 weeks size mass 
felt. Bilateral fornicial fullness was present. Grooves sign could not be 
elicited. P/R-  rectal mucosa free.  
 
3. Investigation  
  Ultrasound pelvis showed a complex adnexal mass with solid cystic 
components seen in the pelvis measuring 9 x 7 cms with internal septations. 
Vascularity was seen in the cyst wall and the septations. Thus, bilateral 
ovaries could not be visualised separately. Minimal ascites present.  
Fig 1                     Fig 2 
CT (sagittal section) of pelvis showing ovarian    CT (coronal section) of Pelvis tumor 
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Fig 3  CT (transverse section) of pelvis. 
 
  CT pelvis showed a well differentiated thin walled lesion 10 x 7.2 x 
13 cm with mixed fat and soft tissue density of 5 x 4 cm within it. These 
features suggest a right dermoid  cyst.  An ill differentiated lobulated lesion 
of 9 x 7 x 9 cm with solid and cystic components in the mid line of pelvis 
and which is slightly towards left side is seen. These features are suggestive 
of ovarian malignancy. (Fig 1,2,3) 
  Blood investigations showed normal Ca 125 value. Patient had 
increased BUN and creatinine values and hence diagnosed to have stage 2 
CKD.  
  The patient was then taken up for staging laparotomy. 
Intraoperatively, a large dermoid cyst 10 x 10 cms with sebaceous material, 
hair and calcareous material was removed and was taken for frozen section. ( 
Fig 4).Uterus was atrophic. In the left iliac  region, a hard mass (3 x 4 cms ) 
with omental adhesions was seen.  It was removed and sent for frozen 
section. Omental biopsy was sent for histopathology. Frozen section showed 
features suggestive of malignancy. Hence, total abdominal hysterectomy 
with bilateral saphingoopherectomy was done, and the final histopathology 
report showed grade III T2b Nx Mo – poorly differentiated carcinoma in 
teratoma of ovary(Fig 5) with omental deposits and involvement of other 
adenexa. Oncology opinion was obtained and advised for six cycles of 
chemotherapy.  The patient underwent only one cycle of chemotherapy with 
bleomycin and etoposide but did not follow up with us farther. 
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Fig 4                                                                                Fig 5 
Gross appearance of the mature cystic teratoma                   Microscopic appearance showing 
showing hair and sebaceous material.                               malignant cells in the tumor 
 
4. Discussion 
  MCT accounts for 10–20 % of all ovarian tumors in  women within 
the reproductive age [Kurman R.J et al 2002], while malignant 
transformation of mature teratoma is more common after the age of 50yrs 
.SCC arising from an MCT is a rare pathologic event and in most instances 
not diagnosed preoperatively. Thus, there are no particular signs or 
symptoms which are characteristic of malignancy arising in a dermoid cyst. 
The common symptom is abdominal pain followed by  abdominal or pelvic 
mass, but the patients may be asymptomatic or have symptoms of abdominal 
distention or bloated abdomen, as those caused by benign cysts (Spannuth 
WA et al 2005). In some other cases, various symptoms due to invasion of 
nearby organs are the common complaints, and these include gastrointestinal 
symptoms of constipation or diarrhea,  rectal bleeding, or urinary frequency 
(Tangjitgamol S et al 2003). Other non-specific signs of wasting disease such 
as weight loss or cachexia may be found in advanced cases. 
 Preoperative diagnosis of an MCT of the ovary is relatively easy due 
to the radiologic detection of bony tissues which includes teeth, bones, and 
cartilages. 
 However, preoperative diagnosis of malignant transformation is very 
difficult clinically, because this tumor cannot be readily differentiated from 
an uncomplicated MCT or other ovarian tumors (Kurman et al 2002). Since 
MCT is a common ovarian neoplasm and is increasingly diagnosed as an 
incidental finding in patients, there has been growing emphasis on 
preoperative risk assessment of these tumors in order to optimize surgical 
management. Also, there  are evidence’s for some risk factors for 
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malignancy in MCT which includes age, tumor size, and serum tumor 
markers. 
 SCC arising in an MCT has historically been observed in relatively 
older patients, particularly those after menopause; although, it has been 
sometimes reported in young patients who are around 30 years of age (Kurtz 
JE et al 1999, Wen KC et al 2006) or even younger (Rim SY et al 2006, 
Tseng CJ et al 1996). A couple of studies demonstrated  the role of patient’s 
age in differential diagnosis as it is prudent to maintain a higher suspicion of 
malignancy in MCTs occurring in patients over the age of 45 (Kikkawa F et 
al 1997).  
 Tumor size has also been noted to predict malignancy. Although 
MCT presents in a wide range of sizes, larger tumors correlate with an 
increased risk of malignant transformation. Kikkawa et al. reported that a 
tumor diameter of larger than 9.9 cm was 86% sensitive for malignancy in 
their series10. In general, it is recommended that a diameter equal or greater 
than 10 cm or a tumor arising in an ovarian MCT demonstrating rapid 
growth should prompt suspicion (Dos Santos et al 2007). 
 The prognosis for these tumors has been often reported to be very 
poor with a five-year survival rate of only 15 – 30%.1 Prognostic indicators 
of survival have been attempted to be identified in various studies, but most 
of them agree that higher FIGO stages would carry a worse prognosis (Tseng 
et al 1996 , Kikkawa F et al 1997,Lee YC et al 1999 , Hirakawa T et al 
1989). 
  The other potential predictors reported include rupture or 
spillage,(Mayer C et al 2002) tumor grade, vascular involvement, and the 
mode of tumor infiltration.(Kikkawa F et al 1997, Hirakawa T et al 1989). 
 In addition, better prognosis has been reported when the malignant 
element is an SCC compared with adenocarcinoma or sarcoma. The main 
therapeutic approach to an ovarian MCT with malignant transformation has 
been surgical.(Tseng et al 1996, Peterson WF et al 1957) Therefore, 
conservative unilateral oophorectomy without further post-operative 
treatment may be justified for early stage IA disease, especially for 
nulliparous and young patients who desire future fertility; however, in the 
post-menopausal women, total removal of the genital organs would seem to 
be the  next line of action (Tseng CJ et al 1996). Post-operative treatments in 
the literature, includes single-agent or combination chemotherapy, 
radiotherapy, or a combination of these modalities. The results of these 
treatment regimens were variable and they have not been systemically 
evaluated in an adequate number. Therefore, the optimal adjuvant therapy for 
SCC arising from an MCT has not been yet established (Tangjitgamol S et al 
2003). 
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5. Conclusion 
 In conclusion, clinicians should keep this rare type of tumour in mind 
when faced with a dermoid cyst, especially in older patients, or in patients 
with larger than usual cysts. Better prognosis has been reported in cases of 
SCC compared with adenocarcinoma or sarcoma [Kikkawa F et al 1998]. 
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